loading

Pliant Therapeutics Inc Azioni (PLRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
22.64%
45.59
58.94 62.01 60.64 52.39
Operating Income/Loss
22.64%
-45.59
-58.94 -62.01 -60.64 -52.39
Income/Loss From Continuing Operations Before Tax
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Net Income/Loss
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.27%
61.39
61.22 60.73 60.38 60.18
Diluted Average Shares
0.27%
61.39
61.22 60.73 60.38 60.18
Basic Earnings Per Share
22.83%
-0.71
-0.92 -0.95 -0.92 -0.78
Diluted Earnings Per Share
22.83%
-0.71
-0.92 -0.95 -0.92 -0.78
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.75
price up icon 0.84%
$84.75
price up icon 0.87%
$24.53
price down icon 9.27%
$103.63
price down icon 0.75%
$133.53
price up icon 0.92%
biotechnology ONC
$299.27
price down icon 3.36%
Capitalizzazione:     |  Volume (24 ore):